China NMPA Drug Inspection - Linzhou Yashen Pharmaceutical Co., Ltd. - Vitamin B6 injection

China NMPA drug inspection for Linzhou Yashen Pharmaceutical Co., Ltd. published November 18, 2019. Drug: Vitamin B6 injection. The Shandong Provincial Food and Drug Administration (SPFDA) released an announcement on June 15, 2017, later re-publish

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Linzhou Yashen Pharmaceutical Co., Ltd.

Inspection Date

Unknown Date

Product Type

ID: 3152ba13-c242-451c-a5cd-5679e6d94f38

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox